Ethionamide
Ethionamide Price range: $ 49,00 through $ 172,00
Back to products
Eukroma Cream
Eukroma Cream Price range: $ 47,00 through $ 151,00

Etodolac

Price range: $ 46,00 through $ 390,00

Etodolac is a highly effective nonsteroidal anti-inflammatory drug (NSAID) specifically developed to target pain and inflammation at the source. This medication is primarily used to manage the symptoms of osteoarthritis and rheumatoid arthritis by reducing joint stiffness and swelling. By inhibiting the body’s production of inflammatory substances, it helps restore comfort and improve overall physical mobility. It is also well-suited for providing reliable relief from various types of acute pain. Incorporating Etodolac into a treatment plan allows for a more active lifestyle by effectively addressing chronic musculoskeletal discomfort.

Active substance: Etodolac
SKU: Etodolac Categories: , ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Etodolac belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is a prescription-only medication approved by the U.S. Food and Drug Administration (FDA) for managing pain and reducing inflammation associated with specific acute and chronic musculoskeletal conditions.

In the United States, etodolac is available strictly by prescription from a licensed healthcare provider and must be dispensed in compliance with applicable federal and state pharmacy regulations. It is supplied in immediate-release and extended-release oral formulations intended for adult patient populations under direct medical supervision.

Property Details
Active ingredient Etodolac
Therapeutic class Nonsteroidal Anti-inflammatory Drug (NSAID)
Dosage form Oral capsule, oral tablet, extended-release tablet
Route of administration Oral
Prescription status Prescription only (Rx)
Storage Store at room temperature 20°C to 25°C (68°F to 77°F)

Clinical Overview and Usage Guidelines

Main uses

Etodolac is indicated primarily for the relief of signs and symptoms associated with osteoarthritis and rheumatoid arthritis. Additionally, immediate-release formulations of etodolac are FDA-approved for the management of acute pain in adult patients. By inhibiting inflammatory pathways, the medication helps attenuate pain signals, reduce swelling, and improve functional mobility in joint tissue. Any off-label applications–such as management of ankylosing spondylitis or soft-tissue inflammation–must be explicitly evaluated and monitored by a qualified healthcare professional, as off-label use carries specific risk-benefit dynamics not formally evaluated in the standard FDA approval process.

How the Drug Works

Etodolac exerts its therapeutic effects by inhibiting the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, which are essential for converting arachidonic acid into prostaglandins. Prostaglandins are primary chemical mediators of inflammation, fever, and pain sensitization throughout the peripheral tissues. Pharmacological studies demonstrate that etodolac exhibits preferential selectivity for the COX-2 isoenzyme relative to COX-1. By suppressing prostaglandin synthesis at inflammatory sites, etodolac diminishes localized inflammatory responses while partially maintaining baseline physiological COX-1 functions in comparison to non-selective NSAIDs.

How it is absorbed and eliminated

Following oral administration, etodolac is rapidly and thoroughly absorbed from the gastrointestinal tract. Peak plasma concentrations are typically achieved within 1 to 2 hours following administration of immediate-release oral capsules or tablets. Extended-release formulations exhibit a prolonged absorption profile, reaching peak plasma concentrations over a period of approximately 5 to 6 hours. Etodolac is highly bound to human serum proteins (>99%), predominantly albumin. The drug undergoes extensive hepatic transformation into hydroxylated and glucuronidated metabolites, which are subsequently eliminated mainly via renal excretion in urine. The terminal elimination half-life of etodolac ranges from 6 to 7 hours in individuals with normal renal function.

Dosing schedule and administration

Dosage regimens for etodolac must be individualized by a licensed prescriber based on the patient’s therapeutic indication, baseline renal and hepatic function, and clinical response. For the management of acute pain, immediate-release doses of 200 mg to 400 mg every 6 to 8 hours are commonly prescribed, with total daily administration not exceeding 1000 mg. For chronic joint disorders such as osteoarthritis or rheumatoid arthritis, daily dosages generally range from 600 mg to 1000 mg daily, divided into two doses or taken once daily using extended-release formulations. Oral dosage forms should be ingested with a full glass of water. Clinical guidelines recommend using the lowest effective dose for the shortest duration compatible with individual treatment goals.

Adverse Reactions

Adverse reactions associated with etodolac therapy primarily involve the gastrointestinal system. Commonly reported reactions include dyspepsia, abdominal pain, nausea, flatulence, diarrhea, and constipation. Central nervous system adverse effects such as headache, dizziness, or somnolence may also occur. Serious and potentially life-threatening adverse reactions associated with the NSAID class include gastrointestinal ulceration, hemorrhage, and perforation, which can develop without warning symptoms. Additionally, etodolac may contribute to renal impairment, sodium and water retention, peripheral edema, and modest elevations in hepatic transaminase enzymes, requiring periodic laboratory evaluation during prolonged administration.

Compatibility with Other Medicines

Etodolac demonstrates important pharmacokinetic and pharmacodynamic interactions when combined with other pharmacologic agents. Co-administration with anticoagulants (such as warfarin), direct oral anticoagulants, or antiplatelet drugs (including aspirin) markedly increases the risk of severe upper and lower gastrointestinal bleeding. Etodolac may diminish the antihypertensive effects of ACE inhibitors, angiotensin receptor blockers (ARBs), and beta-blockers, while simultaneously increasing the risk of hyperkalemia and acute kidney injury when combined with potassium-sparing diuretics. Concurrent administration with lithium can reduce renal clearance of lithium, leading to elevated plasma concentrations and risk of toxicity. Combining etodolac with other systemic NSAIDs or oral corticosteroids significantly exacerbates gastrointestinal mucosal toxicity.

Important Precautions

Etodolac carries a FDA boxed warning concerning severe cardiovascular and gastrointestinal risks. Systemic NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may manifest early in treatment and increases with duration of use. Etodolac is strictly contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery. The drug is also contraindicated in patients with a history of asthma, urticaria, or severe allergic-type reactions following exposure to aspirin or other NSAIDs. Caution and dose adjustments are required when treating elderly patients or individuals with pre-existing renal dysfunction, hepatic impairment, baseline hypertension, or congestive heart failure.

Food and alcohol interactions

Etodolac may be taken with food, milk, or antacids to minimize stomach irritation or gastrointestinal discomfort. Administering etodolac with food does not alter the overall bioavailability (extent of absorption) of the active drug, though it may slightly delay the rate of peak concentration. Patients taking etodolac should avoid or strictly limit the consumption of alcoholic beverages. Combining alcohol with nonsteroidal anti-inflammatory agents heightens mucosal toxicity and increases the baseline risk of gastric mucosal erosion and gastrointestinal bleeding.

Red flags

Patients should be instructed to seek immediate emergency medical care if they experience signs of severe adverse reactions while taking etodolac. Critical signs include manifestations of severe hypersensitivity reactions (such as swelling of the face, lips, tongue, or throat, or acute respiratory distress), symptoms suggestive of gastrointestinal hemorrhage (such as dark, tarry stools, hematemesis, or coffee-ground emesis), or indications of acute cardiovascular events (including sudden chest pain, dyspnea, localized numbness, weakness on one side of the body, or acute slurred speech).

If you skip a dose

If a dose of etodolac is missed, it should be taken as soon as remembered. However, if the time is close to the next scheduled administration, the missed dose should be omitted and the regular schedule resumed. Patients must not double the prescribed dose or administer extra medication to compensate for a missed dose, as exceeding the recommended daily limit increases systemic toxicity and the likelihood of acute renal or gastrointestinal complications.

Storage and expiration

Etodolac dosage forms should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The container must be kept tightly closed and protected from excessive heat, direct light, and ambient moisture. Storage in high-humidity environments, such as bathroom cabinets, should be avoided. The medication must be kept out of reach of children and domestic animals. Expired or unused medication should be disposed of via community medication take-back initiatives or in accordance with standard FDA disposal recommendations.

Frequently Asked Questions

Can etodolac be taken on an empty stomach?

While etodolac can be absorbed when taken on an empty stomach, administering the medication with food, milk, or an antacid is frequently recommended to decrease the likelihood of localized gastrointestinal irritation and stomach upset without compromising total drug absorption.

How long does it take for etodolac to begin reducing pain?

Immediate-release formulations of etodolac typically begin to provide analgesic relief within 30 to 60 minutes after oral ingestion, achieving peak plasma levels within 1 to 2 hours. Extended-release formulations release the active drug gradually over a longer period, providing sustained relief for chronic inflammatory conditions.

Is it safe to take etodolac during pregnancy?

Etodolac should be avoided during pregnancy unless specifically directed by a healthcare provider. Use of NSAIDs at 20 weeks or later in pregnancy may cause rare but serious fetal kidney problems and low amniotic fluid. Additionally, use during the third trimester is strictly contraindicated due to the risk of premature closure of the fetal ductus arteriosus.

Does etodolac cause drowsiness or impact the ability to drive?

Etodolac can cause central nervous system side effects such as dizziness, somnolence, or blurred vision in some individuals. Patients should observe their individual response to the medication before operating heavy machinery, driving a motor vehicle, or engaging in tasks requiring complete mental alertness.

How does etodolac differ from over-the-counter pain relievers?

Etodolac is a potent, prescription-only NSAID that exhibits preferential COX-2 inhibition compared to non-selective over-the-counter NSAIDs like ibuprofen or naproxen. Because of its specific potency, pharmacological profile, and risk of systemic adverse events, its use requires formal medical evaluation and ongoing clinician supervision.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

200mg

,

300mg

,

400mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία